Within the entire study cohort, CAMP serum levels were positively correlated with MCP-1 levels (p = 0.026, rho = 0.239, n = 86) (Figure 7C), whereas a negative correlation was observed in ACS-1 patients (p = 0.030, rho = −0.512, n = 18). The gene discussed is CCL2; the disease is Apert syndrome.